Skip to main content

The Wistar Institute

|

The Wistar Institute Receives Two Biomedical Research Grants from the V Foundation for Cancer Research

PHILADELPHIA — (December 10, 2024) — The Wistar Institute assistant professors Nan Zhang, Ph.D., and Noam Auslander Ph.D., have both received independent funding totaling $1.2 million over the next three years for cancer research projects from the V…
Read more
|

Wistar Institute Researchers Design Novel Immunotherapy for Brain Cancer

PHILADELPHIA — (December 3rd, 2024) — The Wistar Institute’s David B. Weiner, Ph.D. — Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished Professor in Cancer Research — and his lab h…
Read more
|

The Wistar Institute Awarded $2 Million RACP Grant from Shapiro Administration for New Center for Advanced Therapeutics

PHILADELPHIA — (Nov. 27, 2024) — Governor Josh Shapiro’s Administration, through the Commonwealth of Pennsylvania Redevelopment Assistance Capital Program (RACP), has granted The Wistar Institute $2 million to fund its new Center for Advanced Therap…
Read more
|

Trailblazing Nobel Laureate Dr. Katalin Karikó Meets with Wistar Trainees

Dr. Katalin Karikó, 2023 Nobel Laureate in Physiology or Medicine, received The Wistar Institute’s 2024 Helen Dean King Award and as a part of the day-long activities, Dr. Karikó spent time with Wistar trainees listening, answering their questions a…
Read more
|

The Wistar Institute’s Dr. Rahul Shinde Shares Hopes for Future of Pancreatic Cancer Therapy

For Pancreatic Cancer Awareness Month, we sat down with Rahul S. Shinde, D.V.M., Ph.D., assistant professor in Wistar’s Ellen and Ronald Caplan Cancer Center who researches potential new therapies for treatment-resistant cancers like pancreatic canc…
Read more
|

Wistar Institute Researchers Discover New Combination Therapy Approach for Metastatic Ovarian Cancer

PHILADELPHIA — (November 21, 2024) — The Wistar Institute’s Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center’s Molecular and Cellular Oncogenesis Program, and lab have discovered a new approach to treating ovarian c…
Read more
|

Collaboration between The Wistar Institute and Cameroon Researchers Reveals HIV Latency Reversing Properties in African Plant

PHILADELPHIA — (November 19, 2024) — A collaboration between The Wistar Institute and the University of Buea in Cameroon has uncovered the mechanisms for a medicinal plant with anti-HIV potential in Croton oligandrus Pierre & Hutch, a species of Afr…
Read more
|

Chronic Disease and Corgis: The Varied Interests of Wistar’s Dr. Samantha Soldan

Infectious disease specialist & senior scientist in Wistar’s Lieberman lab, Dr. Soldan studies the connection between M.S. and Epstein Barr Virus. She is most intrigued with how the body responds to disease—why sleeping viruses reactivate, how a…
Read more
|

Mono, Multiple Sclerosis, and Cells That Live Forever: Wistar’s Dr. Paul Lieberman on Progress in EBV Research

Paul M. Lieberman, Ph.D., is leader of the Genome Regulation and Cell Signaling Program at the Ellen and Ronald Caplan Cancer Center. He studies how certain viruses, such as Epstein-Barr virus, establish a long-term latent infection that can lead to…
Read more
|

Maureen Murphy, Ph.D., of The Wistar Institute Named 2024 Woman of Influence

PHILADELPHIA — (October 11, 2024) — In the latest issue of The Philadelphia Business Journal, The Wistar Institute’s Maureen Murphy, Ph.D. — Deputy Director of the Ellen and Ronald Caplan Cancer Center and Ira Brind Professor & Program Leader of the…
Read more